Your Article Summary
See Latest ArticlesAn alternative menaquinone biosynthetic pathway operating in microorganisms: an attractive target for drug discovery to pathogenic Helicobacter and Chlamydia strains
The Journal of Antibiotics, 06/30/09
Dairi T - The authors deduced the outline of the alternative pathway, which branched at chorismate in a similar manner to the known pathway but then followed a completely different pathway. As humans and some useful intestinal bacteria, such as lactobacilli, lack the alternative pathway, it would be an attractive target for the development of chemotherapeutics.
Related Articles
Graffinity Enters into Drug Discovery Research Collaboration with Genentech
b3c newswire, 10/16/09
Relevance Score: 68%
New finding could lead to cure of pulmonary arterial hypertension
Internet Source, 10/26/09
Relevance Score: 66%
The next ten stories on antiviral drug discovery (part E): Advents, Advances, and Adventures
Medicinal Research Reviews, 10/21/09
Relevance Score: 66%
Biomarkers for the Diagnosis and Management of Drug-Induced Liver Injury
Seminars in Liver Disease, 10/16/09
Relevance Score: 65%
United States Patent Office Allows Claims Covering the Approved Administration of Kuvan with Food
BioMarin, 10/01/09
Relevance Score: 65%
Today in Antimicrobials...keeping you current
Receive free subspecialty "5-minute updates" via email
Efficacy and safety of linezolid in methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infection: a meta-analysis
Current Medical Research and Opinion, 12/17/09
Artesunate plus amodiaquine combination therapy: reviewing the evidence
Drug Development Research, 12/17/09
Is antibiotic prophylaxis effective in preventing urinary tract infections in patients with vesicoureteral reflux
Expert Review of Anti-infective Therapy, 12/17/09